M&A - Addus HomeCare Corp
Form Type: 10-K
Filing Date: 2025-02-25
Corporate Action: Acquisition
Type: Update
Accession Number: 000095017025026747
Filing Summary: Addus HomeCare Corporation provides an annual report under Form 10-K for the fiscal year ending December 31, 2024. The document outlines the company's business operations, financial results, and strategic objectives. It highlights the acquisition of Gentiva Health Services, which enhances Addus's service offerings in home health and hospice care. The report details risks associated with the industry, revenue generated from different segments, and operational performance metrics. It also discusses regulatory issues, competitive landscape, and financial commitments through credit agreements. The filing indicates the company's substantial growth within the home care sector and underlines its expanding geographic presence across the United States.
Additional details:
Title: company_name
Value: Addus HomeCare Corporation
Title: fiscal_year_end
Value: 2024-12-31
Title: acquisition_details
Value: Acquisition of Gentiva Health Services
Title: credit_agreement
Value: CapitalOne Credit Agreement
Title: operational_segments
Value: Home Health, Hospice, Personal Care
Title: market_value
Value: 2061491000
Title: common_stock_par_value
Value: 0.001
Title: trading_symbol
Value: ADUS
Form Type: 8-K/A
Filing Date: 2025-02-14
Corporate Action: Acquisition
Type: Update
Accession Number: 000095017025021397
Filing Summary: This amendment updates the original Form 8-K filed on December 2, 2024, by Addus HomeCare Corporation, reporting on the acquisition of the personal care business of Curo Health Services, LLC, conducted by its wholly-owned subsidiary, Addus HealthCare, Inc. Key updates include the inclusion of audited and unaudited financial statements of the acquired business, KAH Hospice Company-Personal Care, as of December 31, 2023, and the nine-month period ended September 30, 2024, along with pro forma combined financial statements. The filing ensures that all financial documentation relevant to the acquisition is now presented alongside the initial disclosures.
Additional details:
Item 9 01 Financial Statements Of Business Acquired: Includes audited financial statements as of December 31, 2023, and unaudited financial statements for the nine months ended September 30, 2024.
Exhibits Description: Includes consent from PricewaterhouseCoopers regarding audited financials, and details of the financial statements.
Comments
No comments yet. Be the first to comment!